Tamsulosin Hydrochloride Capsule
Product Images NDC 55154-2636

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 55154-2636). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.4mg Bag Label (0e3206ba Db3e 40b3 B46b C7ae4703fdea 00)

Label for Tamsulosin Hydrochloride Capsules, USP 0.4 mg, in a package containing 10 capsules. The label notes storage instructions, dosage information, and warnings, including that the package is not child resistant and for institutional use only. The product is distributed by Cardinal Health 107, LLC and manufactured by Major Pharmaceuticals.*

FDA Label Image

Figure 1 Mean Plasma Tamsulosin Hydrochloride Concentrations Following Single-dose Administration Of Tamsulosin Hydrochloride Capsules 0.4 mg Under Fasted And Fed Conditions (n=8) (Tamsulosin Fig1)

A line graph showing mean plasma concentrations of Tamsulosin Hydrochloride over 36 hours following a single 0.4 mg dose of Tamsulosin Hydrochloride capsules. The graph compares plasma levels under fasted and fed conditions, with time (hours) on the x-axis and plasma concentration (ng/mL) on the y-axis. Concentrations peak earlier and higher in the fasted state than in the fed state.*

FDA Label Image

Figure 2a Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 1 (Tamsulosin Fig2)

A line graph titled 'Figure 2A Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 1' that displays mean change over treatment duration in weeks on the x-axis and mean change on the y-axis. The graph compares three treatments: 0.8 mg, 0.4 mg, and placebo, with mean change decreasing over time for all groups, showing greater reduction in symptom score for 0.8 mg, followed by 0.4 mg, and the least for placebo.*

FDA Label Image

Figure 2b Mean Change From Baseline In Total Aua Symptom Score (0 To 35) Study 2 (Tamsulosin Fig3)

A line graph titled 'Figure 2B Mean Change from Baseline in Total AUA Symptom Score (0 to 35) Study 2' showing mean symptom score changes over a treatment duration of up to 13 weeks with last observation carried forward (LOCF). The graph compares three groups labeled as 0.8 mg, 0.4 mg, and placebo, with mean changes plotted on the vertical axis and weeks on the horizontal axis. The 0.8 mg and 0.4 mg treatment groups show greater symptom score reductions compared to placebo over time.*

FDA Label Image

Figure 3a Mean Increase In Peak Urine Flow Rate (ml/sec) Study 1 (Tamsulosin Fig4)

A line graph titled 'Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 1,' displaying mean change in urine flow rate over treatment duration in weeks. It compares three groups: 0.8 mg dose (circles), 0.4 mg dose (triangles), and placebo (squares), showing higher increases for both doses compared to placebo across weeks, with measurements at baseline and multiple weekly intervals up to 13 weeks.*

FDA Label Image

Figure 3b Mean Increase In Peak Urine Flow Rate (ml/sec) Study 2 (Tamsulosin Fig5)

A line graph titled 'Mean Increase in Peak Urine Flow Rate (mL/Sec) Study 2' depicting changes over treatment duration in weeks. The graph compares three treatment groups (0.8 mg, 0.4 mg, and placebo) showing mean change in mL/sec on the y-axis and weeks of treatment on the x-axis, illustrating that 0.8 mg and 0.4 mg treatments result in greater increases compared to placebo.*

FDA Label Image

Chemical Structure (Tamsulosin Str)

Chemical structure of Tamsulosin Hydrochloride, showing its molecular components including aromatic rings, ether groups, and the hydrochloride salt component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.